Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation of Patients Living With Cystic Fibrosis - Item Development
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 1
- 主要终点
- Change in patient experience of symptom management
研究概览
简要总结
The aim of this study is to develop a reliable and valid instrument to measure symptom management (experience and / or management strategies) during exacerbation episodes in CF patients. For the development a sequential exploratory two phase mixed-method study will be applied. In a first step, up to 25 CF patients will be interviewed: approximately 15 CF patients who experienced at least one episode of exacerbation in the past year and approximately CF 10 patients who are currently experiencing an exacerbation. The latter group will be interviewed up to 3 times during and after the antibiotic treatment. The instruments initial item list will be developed on basis of the interviews. Up to five health professionals will rate the items' relevance. In a further step, items' clarity and relevance will be assessed by cognitive debriefing interviews with no more than 10 patients. In the last step (part III), the instrument's preliminary construct and concurrent validity and reliability will be tested in a larger sample up to 150 patients experiencing exacerbation. Patients will be asked to complete the newly developed questionnaires and a set of other questionnaires at one time point. For part III, ethic approval will be asked at a later date (2015).
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Part I A & II:
- •Patients with a confirmed diagnosis of cystic fibrosis
- •Experience of at least one exacerbation during the last year requiring antibiotic treatment (oral or intravenous)
- •Patients with a confirmed diagnosis of cystic fibrosis
- •Experience of an acute exacerbation requiring antibiotic treatment (oral or intravenous)
排除标准
- •Part I & II
- •Do not speak or understand German
- •Inability to verbally communicate
- •Cognitive impairment
结局指标
主要结局
Change in patient experience of symptom management
时间窗: Patients will be followed up for 4 weeks after start of antibiotic treatment
次要结局
未报告次要终点
